These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24055496)

  • 1. A glimpse into the future - Personalized medicine for smoking cessation.
    Bierut LJ; Johnson EO; Saccone NL
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):592-9. PubMed ID: 24055496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways to precision medicine in smoking cessation treatments.
    Chen LS; Horton A; Bierut L
    Neurosci Lett; 2018 Mar; 669():83-92. PubMed ID: 27208830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation.
    Li X; Semenova S; D'Souza MS; Stoker AK; Markou A
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):554-65. PubMed ID: 23752091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism.
    Perez-Paramo YX; Lazarus P
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):333-349. PubMed ID: 33322962
    [No Abstract]   [Full Text] [Related]  

  • 5. 2018 Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation.
    Bierut LJ
    Nicotine Tob Res; 2020 Feb; 22(2):147-151. PubMed ID: 30855677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine use disorder and Neuregulin 3: Opportunities for precision medicine.
    Elder TR; Turner JR
    Adv Pharmacol; 2024; 99():387-404. PubMed ID: 38467488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.
    Ramsey AT; Chen LS; Hartz SM; Saccone NL; Fisher SL; Proctor EK; Bierut LJ
    Transl Behav Med; 2018 Jan; 8(1):7-17. PubMed ID: 29385591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chipping away at the genetics of smoking behavior.
    Amos CI; Spitz MR; Cinciripini P
    Nat Genet; 2010 May; 42(5):366-8. PubMed ID: 20428092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers to optimize the treatment of nicotine dependence.
    Schnoll RA; Leone FT
    Biomark Med; 2011 Dec; 5(6):745-61. PubMed ID: 22103610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leverage of genetic variants proxying smoking intensity to explore the broad health consequences of smoking.
    Gill D
    EClinicalMedicine; 2020 Sep; 26():100498. PubMed ID: 33089119
    [No Abstract]   [Full Text] [Related]  

  • 11. Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.
    Bloom AJ; Hartz SM; Baker TB; Chen LS; Piper ME; Fox L; Martinez M; Hatsukami D; Johnson EO; Laurie CC; Saccone NL; Goate A; Bierut LJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1003-10. PubMed ID: 25072098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue reactivity, in human smokers.
    Chukwueke CC; Kowalczyk WJ; Gendy M; Taylor R; Tyndale RF; Le Foll B; Heishman SJ
    Brain Behav; 2021 Feb; 11(2):e01982. PubMed ID: 33369277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four Actionable Bottlenecks and Potential Solutions to Translating Psychiatric Genetics Research: An Expert Review.
    Bourdon JL; Davies RA; Long EC
    Public Health Genomics; 2020; 23(5-6):171-183. PubMed ID: 33147585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial and full deletion of nicotinic acetylcholine receptor α4 and β2 subunits reduces sensitivity to acute nicotine administration and development of tolerance following chronic nicotine administration.
    Marks MJ; Loetz E; Ortiz NC; Herder PA; Collins AC
    Behav Pharmacol; 2020 Oct; 31(7):688-701. PubMed ID: 32568759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of the Ser9Gly (rs6280) Dopamine D3 receptor polymorphism in nicotine reinforcement and cue-elicited craving.
    Chukwueke CC; Kowalczyk WJ; Di Ciano P; Gendy M; Taylor R; Heishman SJ; Le Foll B
    Sci Rep; 2020 Mar; 10(1):4085. PubMed ID: 32139730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences.
    Bogdan R; Baranger DAA; Agrawal A
    Annu Rev Clin Psychol; 2018 May; 14():119-157. PubMed ID: 29579395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety Sensitivity Physical and Cognitive Concerns in Relation to Smoking-oriented Cognition: An Examination Among Treatment-seeking Adults Who Smoke.
    Langdon KJ; Bakhshaie J; Lopez A; Tavakoli N; Garey L; Raines AM; Kauffman BY; Schmidt NB; Zvolensky MJ
    J Addict Med; 2018; 12(3):212-219. PubMed ID: 29438156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
    Pintarelli G; Galvan A; Pozzi P; Noci S; Pasetti G; Sala F; Pastorino U; Boffi R; Colombo F
    Sci Rep; 2017 Dec; 7(1):16730. PubMed ID: 29196725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective investigation of the synergistic effect of change in anxiety sensitivity and dysphoria on tobacco withdrawal.
    Bakhshaie J; Kulesz PA; Garey L; Langdon KJ; Businelle MS; Leventhal AM; Gallagher MW; Schmidt NB; Manning K; Goodwin R; Zvolensky MJ
    J Consult Clin Psychol; 2018 Jan; 86(1):69-80. PubMed ID: 29172591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights Into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment.
    Liu W; Li MD
    Curr Neuropharmacol; 2018; 16(4):350-370. PubMed ID: 28762314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.